Drug Use Investigation for XYZAL

Trial Profile

Drug Use Investigation for XYZAL

Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Jun 2013 Planned End Date changed from 1 Apr 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 05 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top